Bard Stent Grafts Don't Infringe Gore Patents, Jury Finds
A Delaware federal jury of four men and four women determined Wednesday that an ultrathin stent graft device produced by C.R. Bard Inc. does not infringe a patent held by W.L....To view the full article, register now.
Already a subscriber? Click here to view full article